Search for: "RANBAXY INC"
Results 81 - 100
of 142
Sorted by Relevance
|
Sort by Date
3 Jun 2015, 9:55 am
Actavis, Inc., 133 S. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
18 Mar 2010, 2:30 am
Amgen, Inc. [read post]
2 Jan 2014, 10:45 pm
For details, see Ranbaxy. [read post]
13 May 2010, 4:58 pm
Ranbaxy Inc. et al. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
17 Jan 2011, 9:27 am
USA, Inc. v. [read post]
21 Oct 2009, 6:13 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Senate Judiciary Committee passes bill against “pay for delay” drug settlements (Prior Art) (Patently-O) (Patent Docs) Valcyte (Valganciclovir) – US: District Court New Jersey finds Roche’s Valcyte patent valid and not infringed by Ranbaxy (Patent Docs) (GenericsWeb) General… [read post]
21 Oct 2009, 5:13 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Senate Judiciary Committee passes bill against "pay for delay" drug settlements (Prior Art) (Patently-O) (Patent Docs) Valcyte (Valganciclovir) - US: District Court New Jersey finds Roche's Valcyte patent valid and not infringed by Ranbaxy (Patent Docs) (GenericsWeb) General Médecins Sans Frontiéres calls on drug… [read post]
21 Oct 2009, 5:13 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Senate Judiciary Committee passes bill against "pay for delay" drug settlements (Prior Art) (Patently-O) (Patent Docs) Valcyte (Valganciclovir) - US: District Court New Jersey finds Roche's Valcyte patent valid and not infringed by Ranbaxy (Patent Docs) (GenericsWeb) General Médecins Sans Frontiéres calls on drug… [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid… [read post]
18 Jul 2014, 11:55 am
Wyeth, Inc., 85 Cal. [read post]
18 Jan 2013, 2:06 pm
The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint following Para IV challenge: Meda… [read post]
27 Jul 2011, 1:01 am
Paddock Laboratories, Inc. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
16 May 2011, 9:07 am
Ranbaxy Pharms., Inc., 336 F.3d 1322, 1329-30 (Fed. [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever changing landscape Pirate Party,… [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
